Form 4: PMV Pharmaceuticals CFO Michael Carulli Sells Shares to Cover Tax Obligations
SEC Form 4
Michael Carulli, CFO of PMV Pharmaceuticals, sold 2,891 shares of common stock on September 11, 2024, to cover tax obligations related to vesting restricted stock units.
Summary
- On September 11, 2024, Michael Carulli, the Chief Financial Officer of PMV Pharmaceuticals, Inc. (PMVP), sold 2,891 shares of the company's common stock.
- The sale was executed at a price of $1.5036 per share.
- The transaction was conducted to cover the reporting person's tax obligation in connection with the vesting of restricted stock units (RSUs).
- Following the transaction, Carulli directly owns 88,395 shares of PMV Pharmaceuticals, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't convey any particularly positive or negative sentiment about the company's performance or future prospects.
Industry Context
Sales of shares to cover tax obligations after vesting of restricted stock units are a common practice among company executives and are generally not indicative of the company's financial health or future prospects.
Stakeholder Impact
- The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect.
Key Dates
| Date | Description |
|---|---|
| 09/11/2024 | Date of stock sale transaction |
| 09/12/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.